Notably, these simulations predicted that CCI-NB01-DMC (diagnosis) would have a lesser ability to activate JNK than CCI-NB02-DMB (diagnosis), which is in line with the innate resistance observed for the original CCI-NB01 patient tumor. The gene discussed is MAPK8; the disease is neoplasm.